Emergency Use Authorization: The ‘New Normal’ For Pharma Vaccines?
April 30, 2021
Paris Prosecutors Take On 3 Probes Into Deaths After AstraZeneca Vaccine
May 6, 2021

Nearly 40 Percent Of US Marines Have Declined COVID-19 Vaccine


“Nearly 40 percent of US Marines are declining COVID-19 vaccinations, according to data provided to CNN.” [Source: cnn.com]


US Marines are hardly alone in choosing to decline experimental COVID-19 vaccinations. Data from the US Centers for Disease Control and Prevention (CDC) suggests that millions of Americans are skipping their second doses of the jabs. A recent report from the Robert Wood Johnson Foundation found more than one-third of nonelderly American adults say they are now unlikely to get vaccinated.

Large numbers of people in Europe also seem unlikely to accept COVID-19 vaccines. A recent survey found almost four in ten people in France and 23 percent in Germany say they definitely or probably won’t get them. In London around one-quarter of National Health Service (NHS) staff are refusing the jabs.

To read how so-called ‘emergency use authorizations’ that bypass the requirement for full clinical trials are becoming the ‘new normal’ in the field of vaccine development, see this article on our website.